UNSPSC 51143204: Acamprosate
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51143200
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51143204
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a neuroprotective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N4K14YGM3J. European Medicines Agency schedules Acamprosate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07366MIG. Acamprosate generally arises in the molecular formula C5H11NO4S.
Read the full definition
The term ACAMPROSATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) ACAMPROSATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acamprosate under HS 29241900 and SITC 51471. As of Q4 2014, ACAMPROSATE remains the US FDA Preferred Term for this commodity. Acamprosate bears US NLM identifiers UMLS ID C0284941 and NCI Concept Code C81691. SMILES: S(=O)(=O)(O)CCCNC(=O)C.
About UNSPSC 51143204
UNSPSC 51143204 Acamprosate, a Commodity code, represents pharmaceutical products and related health-management systems procured by state and local health departments and community health agencies. Recent state and local opportunities under this code show solicitation for naloxone and drug deactivation systems alongside broader pharmacy benefit and prescription-management programs, indicating that the code captures medications and medical interventions addressing substance-use disorders and overdose prevention. The issuing bodies include county health departments and state health and human services agencies; Seminole County, Florida and the Texas Health and Human Services Commission appear as active recent buyers. Procurement activity spans competitive bidding processes for specific pharmaceutical stock and exploratory Request for Information phases for broader pharmacy benefit restructuring.
Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023, under a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities and market intelligence for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting capacity, negotiated net-pricing flexibility, and value-based agreements without specifying formal evaluation criteria or award values at the exploratory stage. Recent activity centers on Florida and Texas, with procurement spanning both routine pharmaceutical supply replenishment and strategic pharmacy-benefit program redesign.
Quick answers
What is UNSPSC 51143204?
UNSPSC 51143204 is Acamprosate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51143204?
UNSPSC 51143204 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51143204
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code